Correlation Between IShares Biotechnology and IShares Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both IShares Biotechnology and IShares Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Biotechnology and IShares Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between iShares Biotechnology ETF and iShares Pharmaceuticals ETF, you can compare the effects of market volatilities on IShares Biotechnology and IShares Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Biotechnology with a short position of IShares Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Biotechnology and IShares Pharmaceuticals.

Diversification Opportunities for IShares Biotechnology and IShares Pharmaceuticals

0.6

Correlation Coefficient

IShares Biotechnology  IShares Pharmaceuticals

Poor diversification

The 3 months correlation between IShares and IShares is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding iShares Biotechnology ETF and iShares Pharmaceuticals ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Pharmaceuticals and IShares Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Biotechnology ETF are associated (or correlated) with IShares Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Pharmaceuticals has no effect on the direction of IShares Biotechnology i.e., IShares Biotechnology and IShares Pharmaceuticals go up and down completely randomly.

Pair Corralation between IShares Biotechnology and IShares Pharmaceuticals

Considering the 90-day investment horizon iShares Biotechnology ETF is expected to under-perform the IShares Pharmaceuticals. In addition to that, IShares Biotechnology is 1.23 times more volatile than iShares Pharmaceuticals ETF. It trades about -0.02 of its total potential returns per unit of risk. iShares Pharmaceuticals ETF is currently generating about 0.11 per unit of volatility. If you would invest  6,902  in iShares Pharmaceuticals ETF on November 28, 2024 and sell it today you would earn a total of  383.00  from holding iShares Pharmaceuticals ETF or generate 5.55% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

iShares Biotechnology ETF  vs.  iShares Pharmaceuticals ETF

iShares Biotechnology ETF

Risk-Adjusted Performance

Very Weak

Over the last 90 days iShares Biotechnology ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental drivers, IShares Biotechnology is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

iShares Pharmaceuticals

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in iShares Pharmaceuticals ETF are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical indicators, IShares Pharmaceuticals is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with IShares Biotechnology and IShares Pharmaceuticals

The main advantage of trading using opposite IShares Biotechnology and IShares Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Biotechnology position performs unexpectedly, IShares Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Pharmaceuticals will offset losses from the drop in IShares Pharmaceuticals' long position.

The idea behind iShares Biotechnology ETF and iShares Pharmaceuticals ETF pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.